Participation of nitric oxide and cyclic GMP in the supersensitivity of acute diabetic rat myocardium by cholinergic stimuli

Biochemical Pharmacology

Volumn 55, Issue 12, 1998, Pages 1991-1999

  Wald, Miriam R ^a   Borda, Enri S ^a   Sterin Borda, Leonor ^a,b  

^a Catedra de Farmacol de la F ^*  (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Cholinergic stimuli; Cyclic GMP; Diabetic heart; Nitric oxide

Indexed keywords

ARGININE; ATROPINE; CARBACHOL; CHOLINERGIC RECEPTOR; CYCLIC GMP; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OTENZEPAD; PIRENZEPINE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERSENSITIVITY;

ANIMALS; CARBACHOL; CARDIOMYOPATHIES; CYCLIC GMP; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCARINIC AGONISTS; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SECOND MESSENGER SYSTEMS;

EID: 0032525737     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00069-0     Document Type: Article

References (40)

1. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population Sixteen year follow-up study . Diabetes. 23:1974;105-111.
2. Jarrett RJ. Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab Rev. 5:1989;547-558.
3. Ewing DJ, Campbell IW, Clarke BF. Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med. 92:1980;308-311.
4. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther. 8:1994;65-73.
5. Bell DS. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care. 18:1995;708-714.
6. Tomlinson KC, Gardiner SM, Bennett T. Diabetes mellitus in Brattleboro rats Cardiovascular, fluid and electrolyte status . Am J Physiol. 256:1989;R1279-R1285.
7. Tomlinson KC, Gardiner SM, Hebden RA, Bennett T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev. 44:1992;103-150.
8. Vadlamudi RVSV, McNeill JH. Effect of alloxan- and streptozotocin-induced diabetes on isolated rat heart responsiveness to carbachol. J Pharmacol Exp Ther. 225:1983;410-415.
9. Li XS, Tanz RD, Chang KSK. Effect of age and methacholine on the rate and coronary flow of isolated hearts of diabetic rats. Br J Pharmacol. 97:1989;1209-1217.
10. Wong KK. Cardiac response to autonomic drugs in atria of diabetic mouse. J Pharm Pharmacol. 46:1994;513-514.
11. Carrier GO, Edwards AD, Aronstam RS. Cholinergic supersensitivity and decreased number of muscarinic receptors in atria from short-term diabetic rats. J Mol Cell Cardiol. 16:1984;963-965.
12. Kofo-Abayomi A, Lucas PD. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil. J Pharm Pharmacol. 39:1987;1019-1021.
13. Wald M, Pascual J, Sterin-Borda L. Role of thromboxanes in alterations of the diabetic β-adrenergic system. Biochem Pharmacol. 38:1989;3347-3355.
14. 2+-ATPase activity in diabetic rat heart. Can J Cardiol. 4:1988;97-101.
15. Van Rossum JM. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 143:1963;299-330.
16. Sterin-Borda L, Vila Echague A, Perez Leiros C, Genaro A, Borda E. Endogenous nitric oxide signalling system and the cardiac muscarinic acetylcholine receptor-inotropic response. Br J Pharmacol. 115:1995;1525-1531.
17. Goin JC, Borda ES, Perez-Leiros C, Storino R, Sterin-Borda L. Identification of antibodies with muscarinic cholinergic activity in human Chagas disease Pathological implications . J Auton Nerv Syst. 47:1994;45-52.
18. Mundson PJ, Rodbard D. LIGAND A versatile computerized approach for characterization of ligand-binding systems . Anal Biochem. 107:1980;220-239.
19. Wald MR, Borda ES, Sterin-Borda L. Mitogenic effect of erythropoietin on neonatal rat cardiomyocytes Signal transduction pathways . J Cell Physiol. 167:1996;461-468.
20. Genaro AM, Boscá L. Early signals in alloantigen induced B-cell proliferation. Comparison between B-cell triggering by intact allogeneic cells and solubilized alloantigen. J Immunol. 151:1993;1832-1843.
21. Berridge MJ, Downes CP, Hauley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J. 206:1982;587-595.
22. 3H] inositol on silica gel glass-fiber sheets. J Chromatogr. 120:1976;502-505.
23. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cyclic GMP levels in the cerebellum. Proc Natl Acad Sci USA. 86:1989;9030-9033.
24. Brown BL, Albano JDM, Elkins RP, Sherzi AM. A simple and sensitive saturation assay method for the measurement of adenosine 3′,5′-cyclic monophosphate. Biochem J. 121:1971;561-562.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
26. 50) of an enzymatic reaction. Biochem Pharmacol. 22:1973;3099-3108.
27. Sterin-Borda L, Cremaschi G, Genaro AM, Vila Echague A, Goin JC, Borda E. Involvement of nitric oxide synthase and protein kinase C activation on chagasic antibodies action upon cardiac contractility. Mol Cell Biochem. 161:1996;75-82.
28. Jackson CV, McGrath GM, McNeill JH. Alterations in alpha 1-adrenoceptor stimulation of isolated atria from experimental diabetic rats. Can J Physiol Pharmacol. 64:1986;145-151.
29. Wald M, Borda ES, Sterin-Borda L. α-Adrenergic supersensitivity and decreased number of α-adrenoceptors in heart from acute diabetic rats. Can J Physiol Pharmacol. 66:1988;1154-1160.
30. Bergh CH, Hjalmarson A, Sjogren KG, Jacobsson B. The effect of diabetes on phosphatidylinositol turnover and calcium influx in myocardium. Horm Metab Res. 20:1988;381-386.
31. Wichelhaus A, Russ M, Petersen S, Eckel J. G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from streptozotocin-diabetic rats. Am J Physiol. 267:1994;H548-H555.
32. Rosen P, Ballhausen T and Stockklauser K, Impairment of endothelium dependent relaxation in the diabetic rat heart: Mechanisms and implications. Diabetes Res Clin Pract 31 Suppl: S143-S155, 1996.
33. Makimattila S, Mantysaari M, Groop PH, Summanen P, Virkamaki A, Schlezka A, Fagerudd J, Yki-Jarvinen H. Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation. 95:1997;618-625.
34. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA. 90:1993;347-351.
35. Han X, Shimoni Y, Giles WR. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J Physiol (Lond). 476:1994;309-314.
36. Grocottmason R, Anning P, Evans H, Lewis MJ, Shah AM. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol. 36:1994;H1804-H1813.
37. Levi RC, Alloatti G, Penna C, Gallo MP. Guanylate-cyclase-mediated inhibition of cardiac ICa by carbachol and sodium nitroprusside. Pflugers Arch. 426:1994;419-426.
38. Golfman LS, Takeda N and Dhalla NS, Cardiac membrane calcium-transport in alloxan-induced diabetes in rats. Diabetes Res Clin Pract 31: Suppl: S73-S77, 1996.
39. Lagadic-Gossmann D, Buckler KJ, Le-Prigent K, Feuvray D. Altered calcium handling in ventricular myocytes isolated from diabetic rats. Am J Physiol. 270:1996;H1529-H1537.
40. i mobilization in diabetic cardiomyocytes Responses to caffeine, KCl, ouabain and ATP . Diabetes Res Clin Pract. 30:1995;9-20.